Spots Global Cancer Trial Database for lymphocytic leukemia, chronic
Every month we try and update this database with for lymphocytic leukemia, chronic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia | NCT00431873 | Lymphocytic Leu... | MGCD0103 | 18 Years - | Mirati Therapeutics Inc. | |
| Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant | NCT00143845 | Multiple Myelom... Lymphocytic Leu... Lymphoma, Low-G... | Reduced intensi... Rapid immunosup... Prophylactic do... | - | University of Michigan Rogel Cancer Center | |
| A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL) | NCT00718549 | Lymphocytic Leu... | Cladribine Cyclophosphamid... Rituximab | 18 Years - | Hoffmann-La Roche | |
| Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00143065 | Lymphoma, Small... Lymphocytic Leu... | Fludarabine Rituximab Alemtuzumab | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b) | NCT01998880 | Lymphocytic Leu... | obinutuzumab rituximab chlorambucil | 18 Years - | Hoffmann-La Roche | |
| A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia | NCT01292603 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine rituximab [MabT... rituximab [MabT... rituximab [MabT... | 18 Years - | Hoffmann-La Roche | |
| An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia | NCT01395615 | Lymphocytic Leu... | 18 Years - | Hoffmann-La Roche | ||
| A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE) | NCT01414205 | Lymphocytic Leu... | Obinutuzumab Corticosteroids | 18 Years - | Genentech, Inc. | |
| A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia. | NCT00532129 | Lymphocytic Leu... | Rituximab Chlorambucil | 18 Years - | Hoffmann-La Roche | |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia | NCT01488162 | Lymphocytic Leu... | 18 Years - | Hoffmann-La Roche | ||
| A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia | NCT01685892 | Lymphocytic Leu... | Obinutuzumab Venetoclax | 18 Years - | Genentech, Inc. | |
| Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00143065 | Lymphoma, Small... Lymphocytic Leu... | Fludarabine Rituximab Alemtuzumab | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia | NCT01292603 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine rituximab [MabT... rituximab [MabT... rituximab [MabT... | 18 Years - | Hoffmann-La Roche | |
| Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia | NCT02242942 | Lymphocytic Leu... | Chlorambucil Venetoclax Obinutuzumab | 18 Years - | Hoffmann-La Roche | |
| A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) | NCT02500407 | Lymphocytic Leu... Lymphoma, Non H... | BTCT4465A (Mosu... Atezolizumab BTCT4465A (Mosu... | 18 Years - | Genentech, Inc. | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a) | NCT01010061 | Lymphocytic Leu... | obinutuzumab rituximab chlorambucil | 18 Years - | Hoffmann-La Roche | |
| A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) | NCT02533401 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine Rituximab | 18 Years - | Hoffmann-La Roche | |
| A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL) | NCT00718549 | Lymphocytic Leu... | Cladribine Cyclophosphamid... Rituximab | 18 Years - | Hoffmann-La Roche | |
| A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia. | NCT00532129 | Lymphocytic Leu... | Rituximab Chlorambucil | 18 Years - | Hoffmann-La Roche | |
| A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) | NCT02533401 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine Rituximab | 18 Years - | Hoffmann-La Roche | |
| A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) | NCT02533401 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine Rituximab | 18 Years - | Hoffmann-La Roche | |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia | NCT01488162 | Lymphocytic Leu... | 18 Years - | Hoffmann-La Roche | ||
| A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON) | NCT01300247 | Lymphocytic Leu... | Fludarabine Obinutuzumab Bendamustine Cyclophosphamid... | 18 Years - | Genentech, Inc. | |
| A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia | NCT01263704 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine Rituximab | 65 Years - | Hoffmann-La Roche | |
| CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a) | NCT01010061 | Lymphocytic Leu... | obinutuzumab rituximab chlorambucil | 18 Years - | Hoffmann-La Roche | |
| CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b) | NCT01998880 | Lymphocytic Leu... | obinutuzumab rituximab chlorambucil | 18 Years - | Hoffmann-La Roche | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia | NCT01685892 | Lymphocytic Leu... | Obinutuzumab Venetoclax | 18 Years - | Genentech, Inc. | |
| A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia | NCT01263704 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine Rituximab | 65 Years - | Hoffmann-La Roche | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia | NCT02242942 | Lymphocytic Leu... | Chlorambucil Venetoclax Obinutuzumab | 18 Years - | Hoffmann-La Roche | |
| A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia | NCT01263704 | Lymphocytic Leu... | Cyclophosphamid... Fludarabine Rituximab | 65 Years - | Hoffmann-La Roche | |
| CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia | NCT04704323 | Lymphocytic Leu... SLL | CAP-100 | 18 Years - | Catapult Therapeutics | |
| CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2) | NCT02053610 | Lymphocytic Leu... | obinutuzumab rituximab chlorambucil | 18 Years - | Hoffmann-La Roche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
